Exciting advancements are shaping the future of clinical trials. Anju’s CEO, Larry Birch, was recently interviewed by Moe Alsumidaie from The Clinical Trial Vanguard on the critical role of AI and digital tech in research. Larry shared his insights on integrating AI in clinical research, the importance of diversity, along with the potential and challenges of Decentralized Clinical Trials (DCTs). Access the full interview here to learn about the transformative impact of these technologies on the clinical trial landscape.
About Larry:
Larry Birch has spent the last 30 years as a standout leader in SaaS and Life Science Technologies. Before his time as Chief Executive Officer of Anju, Mr. Birch held leadership positions in different sectors including general management and finance. During his time at Anju, Larry has been able to deliver optimal corporate strategy solutions to drive growth, performance, and customer satisfaction.
About Moe:
Moe Alsumidaie is Chief Editor of The Clinical Trial Vanguard. Moe holds decades of experience in the clinical trials industry. Moe also serves as Head of Research at CliniBiz and Chief Data Scientist at Annex Clinical Corporation.